Given the above mechanisms of cardiovascular action of PCSK9, some of which are independent of its effects on LDLR and plasma LDLc concentrations, the strategies currently used to eliminate PCSK9 may have broader significance beyond the treatment of hypercholesterolaemia. The gene discussed is PCSK9; the disease is Hypercholesterolemia.